Zensar Technologies Limited (ZENSARTECH) — Board Meeting | 31 July 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. effective August 1, 2026
🔄 What Changed
Effective date of Bridgeview merger; M3BI merger still pending
🔮 What's Next
No forward guidance provided
💡 Investor Takeaway
The completed merger may enhance Zensar's US operational footprint but leaves one subsidiary merger unresolved.

Zensar Technologies announced that the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. became effective on August 1, 2026, after completing filings with US authorities on July 30, 2026, and receiving confirmation at 03:00 a.m. IST on July 31, 2026. The merger of M3BI LLC remains pending.

📄 View Original Announcement (PDF)

About Zensar Technologies Limited (ZENSARTECH)

Information Technology · IT - Software · Listed on NSE

Market Cap: ₹10,459.73 Cr P/E: 13.4 ROE: 16.4% ROCE: 22.0% Div Yield: 2.74%

View full ZENSARTECH stock details →

📡 Get AI alerts when ZENSARTECH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZENSARTECH — Free

📊 More ZENSARTECH filings

See all ZENSARTECH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZENSARTECH files new disclosures

Track ZENSARTECH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ZENSARTECH — Free

Free account · 2 AI queries/day